LivaNova PLC Proceeds from Short-term Debt, Maturing in More than Three Months
LivaNova PLC (LIVN) reported Proceeds from Short-term Debt, Maturing in More than Three Months of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths · last filed 2023-02-27
- LivaNova PLC proceeds from short-term debt, maturing in more than three months for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- LivaNova PLC proceeds from short-term debt, maturing in more than three months for the quarter ending 2021-09-30 was $0.00.
- LivaNova PLC proceeds from short-term debt, maturing in more than three months for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- LivaNova PLC proceeds from short-term debt, maturing in more than three months for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- LivaNova PLC proceeds from short-term debt, maturing in more than three months for fiscal 2022 was $0.00.
- LivaNova PLC proceeds from short-term debt, maturing in more than three months for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- LivaNova PLC proceeds from short-term debt, maturing in more than three months for fiscal 2020 was $47.05M.
- LivaNova PLC proceeds from short-term debt, maturing in more than three months for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
| Period end | Proceeds from Short-term Debt, Maturing in More than Three Months 3 month | Proceeds from Short-term Debt, Maturing in More than Three Months 6 month | Proceeds from Short-term Debt, Maturing in More than Three Months 9 month | Proceeds from Short-term Debt, Maturing in More than Three Months 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-27 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $0.00 derived: sum of 2 quarters · filed 2023-02-27 | $0.00 derived: sum of 3 quarters · filed 2023-02-27 | $0.00 10-K · filed 2023-02-27 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $0.00 derived: sum of 2 quarters · filed 2021-11-03 | $0.00 10-Q · filed 2021-11-03 | $336.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $0.00 10-Q · filed 2021-07-28 | $336.00K derived: sum of 3 quarters · filed 2023-02-27 | $336.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $0.00 10-Q · filed 2021-04-28 | $336.00K derived: sum of 2 quarters · filed 2023-02-27 | $336.00K derived: sum of 3 quarters · filed 2023-02-27 | $938.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $336.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $336.00K derived: sum of 2 quarters · filed 2023-02-27 | $938.00K derived: sum of 3 quarters · filed 2023-02-27 | $47.05M 10-K · filed 2023-02-27 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $602.00K derived: sum of 2 quarters · filed 2021-11-03 | $46.72M 10-Q · filed 2021-11-03 | $46.72M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $602.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $46.72M 10-Q · filed 2021-07-28 | $46.72M derived: sum of 3 quarters · filed 2022-03-01 | $46.72M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $46.12M 10-Q · filed 2021-04-28 | $46.12M derived: sum of 2 quarters · filed 2022-03-01 | $46.12M derived: sum of 3 quarters · filed 2022-03-01 | $46.12M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $0.00 10-K · filed 2022-03-01 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $0.00 derived: sum of 2 quarters · filed 2020-10-29 | $0.00 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $0.00 10-Q · filed 2020-07-29 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-04-30 | |||
| 2018-12-31 | $240.00M 10-K · filed 2021-03-01 | |||
| 2017-12-31 | $20.00M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |